Skip to main content
Back to CDP Venture Capital

CDP Venture Capital's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by CDP Venture Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$216.2M

Therapeutics Portfolio Companies (4)

Export
Therapeutics

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

Brescia, Italy
September 2022
$2.5M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Milan, Italy
September 2024
$52.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

Helsinki, Finland
March 2025
$20.6M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Milano, Italy
November 2025
$141.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore CDP Venture Capital's Full Portfolio

View all companies funded by CDP Venture Capital across every industry and funding stage.

View Full CDP Venture Capital Portfolio